why choose us

First received: November 26, 2024

Clinical Trial: A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double-Blind, Third-Party Open, Placebo-Controlled, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, Tolerability, Immunogenicity, and Pharmacodynamics Following Intr

Brief Summary: The purpose of this study is to learn if the study medicine (called PF-07264660) is safe and how it is processed in healthy Chinese participants.This study is seeking participants who:are between 18 to 65 years of age.are Chinese participants who are overtly healthy as determined by medical evaluation.have a BMI (body mass index) of 19 to 28 kilogram per meter squared; and a total body weight of more than50 kilograms (110 pounds).All participants in this study will receive study medicine.Three-fourths will receive…

Read more